Taconic Biosciences Improves rasH2 Carcinogenicity Test System Access in Asia-Pacific Region

RENSSELAER, N.Y., March 21, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd. (NSI) an...

Related Keywords

Denmark ,Malaysia ,Japan ,United States ,Thailand ,India ,Singapore ,China ,Bangkok ,Krung Thep Mahanakhon ,Indonesia ,America ,Michael Seiler ,Russell Burch ,Taconic Biosciences ,Nomura Jimusho ,Aidan Bouchelle ,Ryuta Nomura ,Japan Inc ,Nomura Siam International Co Ltd ,Nomura Siam International Co ,Drug Administration ,Central Institute For Experimental Animals ,Taconic Biosciences Inc ,Aboutnomura Siam International Co ,Technical Service Center ,European Medicines Agency ,Nomura Jimusho Inc ,Carcinogenicity Test System ,Central Institute ,Experimental Animals ,North America ,Nomura Siam International ,Siam International ,Genetically Engineered ,Animal Model ,Drug Discovery ,Rash2 ,Society Of Toxicology ,Preclinical ,Carcinogenicity ,In Vivo Research ,